Please assess the completion status of the following clinical trial:

Trial Title: Antisecretory Factor (AF) Effects on Intraocular-pressure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* open angle glaucoma, ocular hypertension~Exclusion Criteria:~* other types of glaucoma, other types of ocular comorbidity, previous intra-ocular surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo and Salovum (Type: EXPERIMENTAL): 6 times 4 gr placebo/Salovum day 1-2, 5 times 4 gr placebo/Salovum day 3-5, 4 times 4 gr placebo/Salovum day 6-14
- Salovum and placebo (Type: EXPERIMENTAL): 6 times 4 gr Salovum/placebo day 1-2, 5 times 4 gr Salovum/placebo day 3-5, 4 times 4 gr Salovum/placebo day 6-14

Based on this trial design, predict the completion outcome and termination type (if applicable).